GEMI vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GEMI exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a catastrophic ROE of -416.47%. While the company shows strong top-line revenue growth of 39.40%, this is completely offset by a negative gross margin (-25.78%) and an operating margin of -183.54%, indicating that the company loses money on every unit of service provided. The stock is in a technical freefall, down over 84% in the last year, and is consistently missing earnings estimates by wide margins.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GEMI vs JPM: Head-to-Head Comparison
This page compares Gemini Space Station, Inc. (GEMI) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.